Pulmonx Corporation Common Stock
$2.07
Market Cap
$85.04M
Shares Outstanding
42.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Oct 1, 2020
Round Lot
100
Locale
US
Day Open
$1.99
Day High
$2.08
Day Low
$1.99
Volume
430.1K
VWAP
$2.04
Prev Close
$1.98
Transactions
--
Acc. Volume
--
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.
Pulmonx Corporation Common Stock (LUNG) closed the 2026-09-18 session at $2.07, up 4.55% versus the previous close (+0.09). The stock opened at $1.99 and traded between $1.99 and $2.08 during that session. Session trading volume was 430K shares. The volume-weighted average price (VWAP) is $2.04.
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.
Pulmonx Corporation Common Stock has a market capitalization of $85.0 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. LUNG is listed on the XNAS exchange. The company employs approximately 296 people. Pulmonx Corporation Common Stock is headquartered in REDWOOD CITY, CA. The recorded listing date is 2020-10-01.
On this page you can find market LUNG stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.